What is the most appropriate management for a pregnant lady in her 28th week of pregnancy with hyperthyroidism, currently on 15mg carbimazole (Carbimazole), presenting with symptoms of hyperthyroidism, low Thyroid-Stimulating Hormone (TSH), and elevated Triiodothyronine (T3) and Thyroxine (T4) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperthyroidism in a Pregnant Woman at 28 Weeks Gestation

Switch to Propylthiouracil (PTU) is the most appropriate management for this pregnant woman in her third trimester with uncontrolled hyperthyroidism on carbimazole. 1, 2

Rationale for Switching to PTU in Third Trimester

  • The American Academy of Family Physicians recommends propylthiouracil (PTU) as the preferred antithyroid medication during the first trimester, while methimazole (carbimazole) is preferred in the second and third trimesters 3
  • However, when a patient on carbimazole shows signs of uncontrolled hyperthyroidism (symptoms plus low TSH, high T3 & T4), switching to PTU is indicated rather than increasing the carbimazole dose 1
  • PTU is considered safer than increasing the dose of carbimazole when faced with breakthrough hyperthyroidism in pregnancy, as higher doses of carbimazole are associated with increased risk of side effects 4

Risks of Inadequate Treatment

  • Untreated or inadequately treated hyperthyroidism during pregnancy can lead to serious maternal and fetal complications, including: 2
    • Increased risk of maternal heart failure
    • Preterm birth
    • Stillbirth
    • Fetal or neonatal hyperthyroidism

Dosing and Monitoring Recommendations

  • When switching to PTU, start with an appropriate dose based on the severity of hyperthyroidism 2
  • Monitor free T4 or Free Thyroxine Index (FTI) every 2-4 weeks to adjust dosage appropriately 1
  • The goal is to maintain free T4 or FTI in the high-normal range using the lowest possible thioamide dosage 2
  • Beta-blockers may be temporarily used to manage symptoms like tremors and palpitations until thyroid hormone levels normalize 2

Important Considerations and Precautions

  • While PTU has been associated with hepatotoxicity, this risk must be balanced against the risks of uncontrolled hyperthyroidism in pregnancy 5
  • The FDA notes that PTU "may be the treatment of choice when an antithyroid drug is indicated during or just prior to the first trimester of pregnancy" 5, but clinical guidelines support its use throughout pregnancy when indicated 1, 2
  • Thyroidectomy should only be considered if the patient does not respond to thioamide therapy or develops severe side effects 2
  • Radioactive iodine is absolutely contraindicated during pregnancy 2

Follow-up Care

  • Inform the newborn's physician about the maternal hyperthyroidism due to the risk of neonatal thyroid dysfunction 2
  • Monitor for signs of agranulocytosis (sore throat and fever) which would require immediate discontinuation of PTU and complete blood count 1
  • After delivery, consider switching back to carbimazole/methimazole for long-term management if needed, as PTU has higher risk of hepatotoxicity with prolonged use 5

References

Guideline

Drug of Choice for Hyperthyroidism in First Trimester Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperthyroidism in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.